Project Details
Short title | A phase IIa efficacy and safety trial with intravenous S95011 in primary Sjögren's Syndrome patients. An international, multicentre, randomized, double-blind, placebo-controlled study |
---|---|
Status | Finished |
Effective start/end date | 1/03/21 → 19/05/23 |
Funding
- Servier